Question

Is stem cell therapy for Liver Cirrhosis worth it?

Honest answer: it depends — and it is not a guaranteed cure. For Liver Cirrhosis, stem cell therapy is investigational, so 'worth it' comes down to your situation, budget and tolerance for uncertainty. It may be worth a consultation if you understand it is investigational, you have checked there is no open trial you qualify for, and the clinic is GMP-certified with transparent pricing. It is not worth it at any price from a clinic that promises a cure or hides its lab and costs. Use our candidacy check and calculator to decide with clear eyes.

How stem cells are studied for Liver Cirrhosis

Liver cirrhosis represents end-stage fibrotic liver disease, characterised by irreversible scar tissue replacing functional hepatocytes, portal hypertension, and loss of synthetic function. Stem-cell investigations focus on whether placental mesenchymal stem cells can reduce hepatic fibrosis, promote hepatocyte regeneration, and modulate the immunological and inflammatory drivers of progression. MSCs secrete hepatoprotective factors and anti-fibrotic cytokines (TGF-β antagonists, HGF, FGF) that may arrest stellate-cell activation and collagen deposition. With 89 registered trials — the largest cohort among studied conditions — and 7 currently recruiting, the biological rationale targets the fibrotic cascade rather than curative reversal of established cirrhosis. Early clinical data suggest potential for slowing decompensation, improving synthetic function markers, and delaying transplantation.

Am I a candidate? → · Liver Cirrhosis: full overview → · Liver Cirrhosis cost → · Cost →

Medically reviewed by StemCellAtlas’s editorial team with Dr Polina Krasenova (Haematologist · Clinical Haematology & Integrative Oncology · 15+ yrs cell therapy) of partner clinic Stem Plus (Sofia), against ISSCR, FDA & EMA guidance. Educational information, not medical advice; figures indicative.

Terapia celular de nivel europeo, sin precios europeos.

Medicina regenerativa certificada GMP en el corazón de la UE — desde 3.000–8.000 €, una fracción de los precios de EE. UU. o Alemania. Protocolos personalizados para pacientes de más de 50 países.

Evaluación médica gratuita